Deletion of AMP-activated protein kinase (AMPK) in donor T cells mitigates graft-versus-host disease without impacting graft-versus-leukemia effects

被引:0
|
作者
Byersdorfer, Craig A.
Beezhold, Kevin J.
Moore, Nathan
Chiaranunt, Pailin
Brown, Rebecca Audrey
机构
来源
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
82.11
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
    Sprangers, Ben
    Fevery, Sabine
    Van Wijmeersch, Bart
    De Somer, Lien
    Waer, Mark
    Billiau, An D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4568 - 4594
  • [32] Allogeneic cytotoxic T lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease.
    Boyer, MW
    Johnson, TS
    Yeager, AM
    Waller, EK
    BLOOD, 1996, 88 (10) : 964 - 964
  • [33] New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects
    Deeg, HJ
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (01) : 15 - 21
  • [34] New Strategies for Prevention and Treatment of Graft-versus-Host Disease and for Induction of Graft-versus-Leukemia Effects
    H. Joachim Deeg
    International Journal of Hematology, 2003, 77 : 15 - 21
  • [35] Spontaneous memory CD4+ T cells preserve graft-versus-leukemia without causing graft-versus-host disease.
    Zheng, H
    Matte, CC
    Anderson, BE
    Shlomchik, MJ
    Shlomchik, WD
    BLOOD, 2004, 104 (11) : 172A - 173A
  • [36] Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease
    Krijanovski, OI
    Hill, GR
    Cooke, KR
    Teshima, T
    Crawford, JM
    Brinson, YS
    Ferrara, JLM
    BLOOD, 1999, 94 (02) : 825 - 831
  • [38] RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE - RELATIONSHIP BETWEEN GRAFT-VERSUS-HOST AND GRAFT-VERSUS-LEUKEMIA REACTION
    JACOBSEN, N
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 579 - 579
  • [39] In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
    Choi, Jaebok
    Ritchey, Julie
    Prior, Julie L.
    Holt, Matthew
    Shannon, William D.
    Deych, Elena
    Piwnica-Worms, David R.
    DiPersio, John F.
    BLOOD, 2010, 116 (01) : 129 - 139
  • [40] Differences between graft-versus-leukemia and graft-versus-host reactivity .1. Interaction of donor immune T cells with tumor and/or host cells
    Rocha, M
    Umansky, V
    Lee, KH
    Hacker, HJ
    Benner, A
    Schirrmacher, V
    BLOOD, 1997, 89 (06) : 2189 - 2202